| Dr Kathryn Emily Harvey-feldewerth, DO | |
|
15945 Clayton Rd Ste 310, Ballwin, MO 63011-2493 | |
| (636) 256-5181 | |
| (636) 256-5370 |
| Full Name | Dr Kathryn Emily Harvey-feldewerth |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 6 Years |
| Location | 15945 Clayton Rd Ste 310, Ballwin, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700370996 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2020030345 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Home Health | Saint louis, MO | Home health agency |
| Mercy Hospital St Louis | Saint louis, MO | Hospital |
| Mercy Hospital South | Saint louis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic East Communities | 7214827922 | 491 |
News Archive
Emerging cancer nanotechnology enables target-delivery of substantial payloads of drugs to cancer sites with concomitant reduction of side-effects due to the lesser accumulation in the critical organs.
New research sheds light on why cervical precancers disappear in some women and not in others. Scientists at the Johns Hopkins Kimmel Cancer Center report in the July 1 issue of Clinical Cancer Research that the reason many of these lesions persist is an unlikely mix of human papilloma virus (HPV) strain and a woman's individual immune system.
NEOMED, a not-for-profit organization whose mission is to create a bridge between academic research and the pharmaceutical industry, will receive $12 million in funding from the Government of Canada to help academic researchers turn their early discoveries into future medicines.
A metallic molecule being studied at Rice University begins to glow when bound to amyloid protein fibrils of the sort implicated in Alzheimer's disease. When triggered with ultraviolet light, the molecule glows much brighter, which enables real-time monitoring of amyloid fibrils as they aggregate in lab experiments.
› Verified 6 days ago
| Entity Name | Mercy Hospitals East Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851431738 PECOS PAC ID: 1658276811 Enrollment ID: O20031218000107 |
News Archive
Emerging cancer nanotechnology enables target-delivery of substantial payloads of drugs to cancer sites with concomitant reduction of side-effects due to the lesser accumulation in the critical organs.
New research sheds light on why cervical precancers disappear in some women and not in others. Scientists at the Johns Hopkins Kimmel Cancer Center report in the July 1 issue of Clinical Cancer Research that the reason many of these lesions persist is an unlikely mix of human papilloma virus (HPV) strain and a woman's individual immune system.
NEOMED, a not-for-profit organization whose mission is to create a bridge between academic research and the pharmaceutical industry, will receive $12 million in funding from the Government of Canada to help academic researchers turn their early discoveries into future medicines.
A metallic molecule being studied at Rice University begins to glow when bound to amyloid protein fibrils of the sort implicated in Alzheimer's disease. When triggered with ultraviolet light, the molecule glows much brighter, which enables real-time monitoring of amyloid fibrils as they aggregate in lab experiments.
› Verified 6 days ago
| Entity Name | Mercy Clinic Adult Hospitalists - St. Louis, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841235108 PECOS PAC ID: 6002809944 Enrollment ID: O20040406001004 |
News Archive
Emerging cancer nanotechnology enables target-delivery of substantial payloads of drugs to cancer sites with concomitant reduction of side-effects due to the lesser accumulation in the critical organs.
New research sheds light on why cervical precancers disappear in some women and not in others. Scientists at the Johns Hopkins Kimmel Cancer Center report in the July 1 issue of Clinical Cancer Research that the reason many of these lesions persist is an unlikely mix of human papilloma virus (HPV) strain and a woman's individual immune system.
NEOMED, a not-for-profit organization whose mission is to create a bridge between academic research and the pharmaceutical industry, will receive $12 million in funding from the Government of Canada to help academic researchers turn their early discoveries into future medicines.
A metallic molecule being studied at Rice University begins to glow when bound to amyloid protein fibrils of the sort implicated in Alzheimer's disease. When triggered with ultraviolet light, the molecule glows much brighter, which enables real-time monitoring of amyloid fibrils as they aggregate in lab experiments.
› Verified 6 days ago
| Entity Name | Mercy Clinic East Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851335228 PECOS PAC ID: 7214827922 Enrollment ID: O20070521000006 |
News Archive
Emerging cancer nanotechnology enables target-delivery of substantial payloads of drugs to cancer sites with concomitant reduction of side-effects due to the lesser accumulation in the critical organs.
New research sheds light on why cervical precancers disappear in some women and not in others. Scientists at the Johns Hopkins Kimmel Cancer Center report in the July 1 issue of Clinical Cancer Research that the reason many of these lesions persist is an unlikely mix of human papilloma virus (HPV) strain and a woman's individual immune system.
NEOMED, a not-for-profit organization whose mission is to create a bridge between academic research and the pharmaceutical industry, will receive $12 million in funding from the Government of Canada to help academic researchers turn their early discoveries into future medicines.
A metallic molecule being studied at Rice University begins to glow when bound to amyloid protein fibrils of the sort implicated in Alzheimer's disease. When triggered with ultraviolet light, the molecule glows much brighter, which enables real-time monitoring of amyloid fibrils as they aggregate in lab experiments.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kathryn Emily Harvey-feldewerth, DO 15945 Clayton Rd Ste 310, Ballwin, MO 63011-2493 Ph: (636) 256-5181 | Dr Kathryn Emily Harvey-feldewerth, DO 15945 Clayton Rd Ste 310, Ballwin, MO 63011-2493 Ph: (636) 256-5181 |
News Archive
Emerging cancer nanotechnology enables target-delivery of substantial payloads of drugs to cancer sites with concomitant reduction of side-effects due to the lesser accumulation in the critical organs.
New research sheds light on why cervical precancers disappear in some women and not in others. Scientists at the Johns Hopkins Kimmel Cancer Center report in the July 1 issue of Clinical Cancer Research that the reason many of these lesions persist is an unlikely mix of human papilloma virus (HPV) strain and a woman's individual immune system.
NEOMED, a not-for-profit organization whose mission is to create a bridge between academic research and the pharmaceutical industry, will receive $12 million in funding from the Government of Canada to help academic researchers turn their early discoveries into future medicines.
A metallic molecule being studied at Rice University begins to glow when bound to amyloid protein fibrils of the sort implicated in Alzheimer's disease. When triggered with ultraviolet light, the molecule glows much brighter, which enables real-time monitoring of amyloid fibrils as they aggregate in lab experiments.
› Verified 6 days ago
Dr. Mazin Hazim Kamil, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 15 Remington Place Ct, Ballwin, MO 63021 Phone: 094-122-2052 | |
Dr. Nishant Poddar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15945 Clayton Rd Ste 120, Ballwin, MO 63011 Phone: 636-256-5000 | |
Christine Ann Sigman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15945 Clayton Rd, Suite 310, Ballwin, MO 63011 Phone: 636-256-5350 Fax: 636-256-5370 | |
Dr. David S Rosenberg, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 58 Meadowbrook Cntry Cl Est, Ballwin, MO 63011 Phone: 314-420-6663 Fax: 636-227-2299 | |
Jacob Andrew Zembles, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 15945 Clayton Rd Ste 120, Ballwin, MO 63011 Phone: 636-256-5070 | |
Lauren Bush King, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 15945 Clayton Rd, Suite 340, Ballwin, MO 63011 Phone: 636-256-5130 Fax: 636-256-5147 | |
David M. Schoenwalder, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 15945 Clayton Rd, Suite 310, Ballwin, MO 63011 Phone: 636-256-5350 Fax: 636-256-5372 |